PET helps predict esophageal cancer patients' response to treatment

02/28/2011 | HealthImaging.com

A study published in the Journal of Nuclear Medicine found that textural analysis of tumors based on 18F-FDG PET images proved effective in differentiating among patients with esophageal cancer who were nonresponders, partial responders and complete responders to combined radiochemotherapy. "Although only 18F-FDG images in esophageal cancer have been considered here, clearly the same indices applied in other PET radiotracer studies in the same or different tumor types may help create even stronger links between imaging and underlying tumor biology," researchers concluded.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC